Richard Daniell is VP at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). They have made 24 open-market trades across 1 company since 2018, most recently 2026-05-05.
CIK 0001726096
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TEVA | 55,755 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2026-05-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEVA | SELL | 2026-05-05 | 2026-05-07 | $35.40 | $1.1M | -5.9% | -8.2% | -4.2% |
| TEVA | SELL · 10b5-1 | 2026-03-05 | 2026-03-09 | $31.67 | $548K | -6.2% | -2.7% | +6.0% |
| TEVA | SELL | 2026-03-04 | 2026-03-06 | $32.66 | $3.0M | -3.0% | -2.3% | +12.7% |
| TEVA | SELL | 2026-03-03 | 2026-03-05 | $32.36 | $4.2M | -3.4% | -4.3% | +5.4% |
| TEVA | SELL | 2025-12-09 | 2025-12-11 | $28.68 | $6.6M | +5.1% | +9.3% | +1.6% |
| TEVA | SELL · 10b5-1 | 2025-03-05 | 2025-03-07 | $15.90 | $2.3M | +8.1% | -7.5% | +14.4% |
| TEVA | SELL · 10b5-1 | 2025-03-04 | 2025-03-06 | $15.79 | $4.4M | +7.2% | -9.4% | +13.9% |
| TEVA | SELL · 10b5-1 | 2025-03-03 | 2025-03-05 | $16.06 | $2.0M | +7.3% | -11.4% | +10.3% |
| TEVA | SELL | 2024-08-12 | 2024-08-13 | $17.30 | $3.4M | +7.9% | +4.7% | +1.0% |
| TEVA | SELL · 10b5-1 | 2024-03-05 | 2024-03-07 | $13.52 | $1.3M | -2.5% | +3.7% | +23.3% |
| TEVA | SELL · 10b5-1 | 2024-03-04 | 2024-03-05 | $13.34 | $1.7M | -1.1% | +2.6% | +25.0% |
| TEVA | SELL · 10b5-1 | 2024-02-28 | 2024-03-01 | $13.12 | $541K | +0.5% | +2.4% | +24.4% |
| TEVA | SELL | 2023-03-06 | 2023-03-08 | $9.55 | $1.4M | -11.5% | -2.4% | -25.0% |
| TEVA | SELL | 2023-02-28 | 2023-03-02 | $9.89 | $875K | -10.9% | -8.8% | -28.0% |
| TEVA | SELL | 2022-03-04 | 2022-03-08 | $7.44 | $877K | +4.1% | +34.3% | +19.5% |
| TEVA | SELL | 2022-02-28 | 2022-03-02 | $8.14 | $335K | -7.2% | +18.7% | +15.0% |
| TEVA | SELL | 2022-02-09 | 2022-02-10 | $9.06 | $238K | -9.0% | -16.6% | -16.2% |
| TEVA | SELL | 2021-03-04 | 2021-03-08 | $10.58 | $159K | +5.6% | +5.0% | -0.5% |
| TEVA | SELL · 10b5-1 | 2021-03-03 | 2021-03-04 | $10.88 | $11K | +5.2% | +9.6% | +0.6% |
| TEVA | SELL | 2021-03-01 | 2021-03-02 | $10.85 | $447K | -0.1% | +6.3% | -2.8% |
| TEVA | SELL | 2021-02-09 | 2021-02-11 | $12.72 | $1.7M | +0.2% | -1.3% | -9.1% |
| TEVA | SELL · 10b5-1 | 2020-09-09 | 2020-09-10 | $8.98 | $3K | +0.1% | +6.9% | +20.5% |
| TEVA | SELL · 10b5-1 | 2020-03-17 | 2020-03-19 | $7.17 | $4K | +10.9% | +27.4% | +48.6% |
| TEVA | SELL · 10b5-1 | 2020-03-03 | 2020-03-05 | $11.77 | $12K | -30.8% | -10.8% | +21.4% |
| TEVA | SELL | 2020-02-10 | 2020-02-11 | $12.24 | $152K | -3.0% | -40.4% | -12.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.